Page last updated: 2024-08-16

pindolol and isradipine

pindolol has been researched along with isradipine in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19905 (18.52)18.7374
1990's15 (55.56)18.2507
2000's4 (14.81)29.6817
2010's3 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Balazovjech, I; Dzúrik, R; Fet'kovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J1
Balazovjech, I; Dzúrik, R; Fetkovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J1
Borbás, S; Lengyel, M; Török, E; Zorándi, A1
Blaha, M; Dvorák, I; Nĕmcová, H1
Dvorák, I; Dzúrik, R; Fetkovská, N; Jonás, P; Kotlík, I; Markuljak, I; Petr, P; Widimský, J1
Bristow, MR; Minobe, W; Rasmussen, RP1
Andrén, L; Aurell, M; Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Sievert, A; Svensson, A1
Aström, B; Dahlöf, B; Frithz, G; Hansson, L; Himanen, P; Sundstedt, CD; Tollin, C1
Hof, RP1
Dahlof, B; Hansson, L1
Andrén, L; Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Svensson, A1
Lüscher, TF; Waeber, B1
Fitscha, P; Magometschnigg, D; Meisner, W1
Farsang, C; Holló, J; Jávor, T; Kapocsi, J; Kerkovits, G; Kiss, I; Török, E1
Berne, C; Lind, L; Lithell, H; Pollare, T1
Böhm, M; Erdmann, E; Koch, A; Morano, I; Rüegg, JC; Schwinger, RH1
Fitscha, P; Meisner, W1
Kragie, L; Kwon, YW; Smiehorowski, R1
Magometschnigg, D1
Hansson, L1

Reviews

2 review(s) available for pindolol and isradipine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Isradipine: a profile in essential hypertension.
    Acta anaesthesiologica Scandinavica. Supplementum, 1993, Volume: 99

    Topics: Animals; Captopril; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Pindolol; Quality of Life

1993

Trials

13 trial(s) available for pindolol and isradipine

ArticleYear
[Multicenter study of isradipine in the treatment of hypertension].
    Vnitrni lekarstvi, 1992, Volume: 38, Issue:4

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol

1992
MIS (Multicentric Isradipine Study of antihypertensive therapy).
    Cor et vasa, 1992, Volume: 34, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol

1992
Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
    Journal of cardiovascular pharmacology, 1992, Volume: 19 Suppl 3

    Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiomegaly; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Ventricular Function, Left

1992
Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
    American journal of hypertension, 1991, Volume: 4, Issue:2 Pt 2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Pyridines; Rest

1991
Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
    Cor et vasa, 1990, Volume: 32, Issue:2 Suppl 1

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol; Clinical Trials as Topic; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Pyridines; Smoking

1990
Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 10

    Topics: Adult; Aged; Blood Pressure; Calcium; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Oxadiazoles; Pindolol; Random Allocation

1987
Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    The American journal of medicine, 1989, Apr-17, Volume: 86, Issue:4A

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Placebos; Pyridines

1989
Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    The American journal of cardiology, 1987, Jan-30, Volume: 59, Issue:3

    Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Oxadiazoles; Pindolol; Random Allocation

1987
The long-term effect of isradipine in pindolol-treated patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1987, Volume: 5, Issue:5

    Topics: Aged; Body Weight; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Pyridines

1987
Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Metolazone; Middle Aged; Pindolol

1993
A multicenter study using causal readings, self-recordings, and ambulatory blood pressure monitoring to assess isradipine effects. AMICUS Study Group.
    American journal of hypertension, 1994, Volume: 7, Issue:7 Pt 2

    Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Isradipine; Male; Middle Aged; Pindolol; Self Care

1994
Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
    American journal of hypertension, 1994, Volume: 7, Issue:7 Pt 2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Lipids; Longitudinal Studies; Middle Aged; Pindolol

1994
Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS).
    American journal of hypertension, 1993, Volume: 6, Issue:3 Pt 2

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Treatment Outcome

1993

Other Studies

12 other study(ies) available for pindolol and isradipine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Biochemical pharmacology, 1990, Feb-15, Volume: 39, Issue:4

    Topics: Calcium Channel Blockers; Calcium Channels; Cardiomyopathy, Dilated; Cell Membrane; Humans; Iodocyanopindolol; Isradipine; Kinetics; Myocardium; Nitrendipine; Oxadiazoles; Pindolol; Receptors, Adrenergic, beta; Receptors, Nicotinic

1990
Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties.
    The American journal of cardiology, 1987, Jan-30, Volume: 59, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Consciousness; Drug Interactions; Hemodynamics; Humans; Isradipine; Oxadiazoles; Pindolol; Propranolol; Rabbits; Verapamil

1987
Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment.
    Journal of internal medicine, 1994, Volume: 236, Issue:1

    Topics: Adult; Blood Glucose; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Hemoglobin A; Humans; Hypertension; Insulin; Isradipine; Lipoproteins; Male; Middle Aged; Pindolol; Time Factors

1994
Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:2

    Topics: Adult; Calcium Channels; Diacetyl; Female; Heart; Humans; In Vitro Techniques; Iodocyanopindolol; Isradipine; Male; Middle Aged; Myocardial Contraction; Ouabain; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Sodium-Potassium-Exchanging ATPase

1994
Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement.
    Blood pressure. Supplement, 1994, Volume: 1

    Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol

1994
Rat cardiac calcium channels and their relationships with beta-adrenergic and muscarinic receptors in hypothyroidism.
    Endocrine research, 1993, Volume: 19, Issue:1

    Topics: Animals; Calcium; Calcium Channels; Carbachol; Dose-Response Relationship, Drug; Heart Rate; Hypothyroidism; Iodocyanopindolol; Isoproterenol; Isradipine; Male; Myocardial Contraction; Myocardium; Pindolol; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Muscarinic; Thyroidectomy; Thyroxine

1993